Drug misuse is a major challenge for health professionals in the 21st century, and community pharmacy holds a key place in the management of prescribed medication, the provision of health education and promotion messages to drug users. Two decades ago there would have been no need for a book to describe such the role of community pharmacy; however,
Sets out clear recommendations, based on the best available evidence, for healthcare staff on how to work with people who misuse drugs (specifically opioids, stimulants and cannabis) to significantly improve their treatment and care.
Pharmacy Practice in Developing Countries: Achievements and Challenges offers a detailed review of the history and development of pharmacy practice in developing countries across Africa, Asia, and South America. Pharmacy practice varies substantially from country to country due to variations in needs and expectations, culture, challenges, policy, regulations, available resources, and other factors. This book focuses on each country's strengths and achievements, as well as areas of weakness, barriers to improvement and challenges. It sets out to establish a baseline for best practices, taking all of these factors into account and offering solutions and opportunities for the future. This book is a valuable resource for academics, researchers, practicing pharmacists, policy makers, and students involved in pharmacy practice worldwide as it provides lessons learned on a global scale and seeks to advance the pharmacy profession. - Uses the latest research and statistics to document the history and development of pharmacy practice in developing countries - Describes current practice across various pharmacy sectors to supply a valuable comparative analysis across countries in Africa, Asia, Europe, and South America - Highlights areas of achievement, strengths, uniqueness, and future opportunities to provide a basis for learning and improvement - Establishes a baseline for best practices and solutions
All across the United States, individuals, families, communities, and health care systems are struggling to cope with substance use, misuse, and substance use disorders. Substance misuse and substance use disorders have devastating effects, disrupt the future plans of too many young people, and all too often, end lives prematurely and tragically. Substance misuse is a major public health challenge and a priority for our nation to address. The effects of substance use are cumulative and costly for our society, placing burdens on workplaces, the health care system, families, states, and communities. The Report discusses opportunities to bring substance use disorder treatment and mainstream health care systems into alignment so that they can address a person's overall health, rather than a substance misuse or a physical health condition alone or in isolation. It also provides suggestions and recommendations for action that everyone-individuals, families, community leaders, law enforcement, health care professionals, policymakers, and researchers-can take to prevent substance misuse and reduce its consequences.
Drug misuse is a major challenge for health professionals in the 21st century, and community pharmacy holds a key place in the management of prescribed medication, the provision of health education and promotion messages to drug users. Two decades ago there would have been no need for a book to describe such the role of community pharmacy; however,
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
The Ninth Edition of the best-selling text, Pharmacy Practice and the Law goes beyond preparation for the board exam, helping students understand and critically analyze the law that governs both the profession and the products they distribute. The Ninth Edition continues to include the most up to date federal, legal, regulatory, policy developments, as well as new developments to various medical/pharmaceutical programs. Challenging, open-ended discussion questions and edited cases are included in every chapter to facilitate discussion and critical thinking. Critical issues are discussed in non-legal, easy-to-understand language. Pharmacy Practice and the Law, Ninth Edition is the most comprehensive and engaging resource for teaching the facts of federal pharmacy law and for encouraging critical thinking and analysis on the issues.
Master's Thesis from the year 2011 in the subject Medicine - Pharmacology, Pharmacy, grade: A, Queen's University Belfast, course: Community Pharmacy, language: English, abstract: Title: Patient perspectives to self medication in a community pharmacy setting in Malta. Objective: To determine the perspectives of patients regarding OTC medication, incidence of irresponsible medication, reasons for, predisposing factors that contribute to, and methods used to reduce these events from occurring. The misuse and abuse of OTC medications was also discussed. Design: Questionnaire of approximately 15 minutes duration administered using a structured interview technique. Setting: National Pharmacy, Hamrun, Malta. Subjects: 200 people above the age of 16 years entering the pharmacy. Results: Three quarters of participants visited a community pharmacy at least once a month and over half of participants (56.5%) reported buying OTC drugs during the same period. Most respondents (85%) preferred seeking advice from a chemist rather than a doctor when their condition was not serious enough to visit the latter. Patients with higher managerial, administrative and professional occupations were more likely to follow the directions on the packet. Patients with manual occupations were more likely to seek the advice of a pharmacist rather than a doctor if a given OTC product did not work within a recommended time period. Only 1% of participants asked for an OTC product that did not correspond with the symptoms they were treating. Three quarters of participants were knowledgeable about the potential for abuse of some OTC drugs and most named analgesics as the most liable for abuse. Almost one third (31.5%) of the participants came across cases of OTC abuse. Conclusion: Participants were positive towards the health care being provided by their local pharmacy. They felt that pharmacists play an important role in providing advice on OTC medicines use. The OTC drug abuse problem needs to be tackled urgently as shown by the number of participants witnessing such abuse. Further studies are required to determine on a larger scale the perspectives of OTC use in Malta.
